This
past week, Attorney Generals from 37 states, Guam, Puerto Rico, and the
US Virgin Islands urged the US Food and Drug Administration (FDA) to
regulate E-cigarette advertising, formulation, and sales to minors.
Their case laid out in their letter (PDF)
noted that E-cigarette sales are growing “exponentially”, that there
are no age restrictions on sales or advertising (unlike regular
cigarettes), that E-cigarettes are marketed as safe alternatives to
regular cigarettes, and that they contain flavorings that are “appealing
to youth”.
While E-cigarettes appear to be effective for reducing nicotine withdrawal symptoms in smokers intending to quit, for reducing the numbers of cigarettes smoked by smokers not intending to quit, and for reducing exposure to carcinogens and toxicants found in regular cigarettes, side effects reported in online forums suggest that E-cigarettes induce up to 4 times as many negative as positive side effects.
Further,
E-cigarette retailers offer many candy-like flavored nicotine solutions
(e.g., cotton candy and bubblegum) that seem designed to initiate
E-cigarette use by children, rather than help them quit smoking.
Perhaps more importantly, a recent report analyzing nicotine content in E-cigarette solutions from several brands suggests
that each E-cigarette (with nicotine tank/cartridge volumes ranging
from 1-6 ml) contains amounts of nicotine exceeding lethal doses in
children (10 mg) and adults (40-60 mg) (Figure).
The hazard seems
even greater for E-cigarette liquid refills sold in volumes ranging
from 10-500 ml, which if consumed orally or absorbed transdermally
through the skin, can far exceed lethal nicotine doses even for adults
(67 to 9950 mg).
Thus, the call for E-cigarette regulation by Attorney Generals seems very timely.
CPDDBLOG welcomes CPDD member's thoughts on these issues.
Welcome to the community website for the College on Problems of Drug Dependence (CPDD). CPDD has been in existence since 1929 and is the longest standing group in the United States addressing problems of drug dependence and abuse. This site is intended to be an information resource on substance abuse research, treatment, and related issues for CPDD members, the public, and the media, and a site for commentary by CPDD members and invited guests.